Colircusí Gentadexa
DÁVI Produto Colircusí Gentadexa

Composition

Gentamicin 3.0 mg/ml; Dexamethasone sodium phosphate 1.0 mg/ml and Tetryzoline hydrochloride 0.5 mg/ml

Ear or eye drops, solution

Description

Colircusi Gentadexa is indicated in:

  • Ophthalmology for the topical treatment of ocular surface infections with inflammation caused by microorganisms sensitive to gentamicin, bacterial infections and inflammation in the eyelids and/or conjunctiva, cornea, sclera or episclera.
  • Otology for the topical treatment of bacterial infections of the external auditive channel, such as external otitis and other inflammatory conditions where corticosteroid-antibiotic therapy is indicated.

Prescription-only medicine

Morada da Sede
Estrada Consiglieri Pedroso,
69 B - Queluz de Baixo
2730-055 Barcarena, Portugal
Morada Escritórios e Departamento Comercial
Rua Norberto Oliveira, 1–5
2620-111 Póvoa de Santo Adrião
Telefone
+351 21 434 00 00
(Chamada para rede fixa nacional)
Email e candidaturas
geral@davi.pt
DAVI II – FARMACÊUTICA, S.A.
Estrada Consiglieri Pedroso, 69 B – Queluz de Baixo – 2730-055 Barcarena,
Sociedade Anónima – Matriculada na Conservatória do Registo Comercial de Cascais, sob o nº 508 309 450 Capital Social 217.203,00€
Nº de contribuinte 508 309 450
DÁVI II - FARMACÊUTICA, S.A. – All rights reserved – Privacy Policy – by